Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase

Molecular and Cellular Biology

Volumn 34, Issue 2, 2014, Pages 271-279

  Okur, Mustafa Nazir ^a   Russo, Angela ^a   O'Bryan, John P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERSECTIN; INTERSECTIN 1; PROTEIN SPRY2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; SPROUTY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DEPHOSPHORYLATION; GENE EXPRESSION; HISTONE UBIQUITINATION; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 84891429151     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00850-13     Document Type: Article

References (39)

1. Marmor MD, Yarden Y. 2004. Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23:2057-2070. http://dx.doi.org/10.1038/sj.onc.1207390.
2. Martin NP, Mohney RP, Dunn S, Das M, Scappini E, O'Bryan JP. 2006. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling. Mol. Pharmacol. 70:1643-1653. http://dx.doi.org/10.1124/mol.106.028274.
3. Okur MN, Zhu JO, Fong CW, Martinez N, Garcia-Dominguez C, Rojas JM, Guy G, O'Bryan JP. 2012. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction. Mol. Cell. Biol. 32:817-825. http://dx.doi.org/10.1128/MCB.05647-11.
4. Schmidt MH, Dikic I. 2005. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 6:907-919. http://dx.doi.org/10.1038/nrm1762.
5. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. 2002. The endophilin-CIN85-Cbl complex mediates liganddependent downregulation of c-Met. Nature 416:187-190. http://dx.doi.org/10.1038/416187a.
6. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416:183-187. http://dx.doi.org/10.1038/416183a.
7. Edwin F, Anderson K, Ying C, Patel TB. 2009. Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol. Pharmacol. 76:679-691. http://dx.doi.org/10.1124/mol.109.055848.
8. Guy GR, Jackson RA, YusoffP, Chow SY. 2009. Sprouty proteins: modified modulators, matchmakers or missing links? J. Endocrinol. 203: 191-202. http://dx.doi.org/10.1677/JOE-09-0110.
9. Egan JE, Hall AB, Yatsula BA, Bar-Sagi D. 2002. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc. Natl. Acad. Sci. U. S. A. 99:6041-6046. http://dx.doi.org/10.1073/pnas.052090899.
10. Grossmann KS, Rosario M, Birchmeier C, Birchmeier W. 2010. The tyrosine phosphatase Shp2 in development and cancer. Adv. Cancer Res. 106:53-89. http://dx.doi.org/10.1016/S0065-230X(10)06002-1.
11. Li S, Hsu DD, Wang H, Feng GS. 2012. Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis. Front. Med. 6:275-279. http://dx.doi.org/10.1007/s11684-012-0216-4.
12. Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T, Ishii N, Sugamura K. 2008. c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 28:4805-4818. http://dx.doi.org/10.1128/MCB.01784-07.
13. Hanafusa H, Torii S, Yasunaga T, Matsumoto K, Nishida E. 2004. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J. Biol. Chem. 279:22992-22995. http://dx.doi.org/10.1074/jbc. M312498200.
14. Pan Y, Carbe C, Powers A, Feng GS, Zhang X. 2010. Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development. Development 137:1085-1093. http://dx.doi.org/10.1242/dev.042820.
15. Jarvis LA, Toering SJ, Simon MA, Krasnow MA, Smith-Bolton RK. 2006. Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases. Development 133:1133-1142. http://dx.doi.org/10.1242/dev.02255.
16. He Z, Zhu HH, Bauler TJ, Wang J, Ciaraldi T, Alderson N, Li S, Raquil MA, Ji K, Wang S, Shao J, Henry RR, King PD, Feng GS. 2013. Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38MAPkinase. Proc. Natl. Acad. Sci. U. S. A. 110:E79-E88. http://dx.doi.org/10.1073/pnas.1213000110.
17. Mohney RP, Das M, Bivona TG, Hanes R, Adams AG, Philips MR, O'Bryan JP. 2003. Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK. J. Biol. Chem. 278: 47038-47045. http://dx.doi.org/10.1074/jbc. M303895200.
18. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4:1029-1040. http://dx.doi.org/10.1016/S1097-2765(00)80231-2.
19. Yigzaw Y, Cartin L, Pierre S, Scholich K, Patel TB. 2001. The C terminus of Sprouty is important for modulation of cellular migration and proliferation. J. Biol. Chem. 276:22742-22747. http://dx.doi.org/10.1074/jbc. M100123200.
20. Oldham CE, Mohney RP, Miller SL, Hanes RN, O'Bryan JP. 2002. The ubiquitin-interacting motifs target the endocytic adaptor protein epsin for ubiquitination. Curr. Biol. 12:1112-1116. http://dx.doi.org/10.1016/S0960-9822(02)00900-4.
21. Yu Y, Chu PY, Bowser DN, Keating DJ, Dubach D, Harper I, Tkalcevic J, Finkelstein DI, Pritchard MA. 2008. Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities. Hum. Mol. Genet. 17:3281-3290. http://dx.doi.org/10.1093/hmg/ddn224.
22. Sawasdikosol S. 2010. Detecting tyrosine-phosphorylated proteins by Western blot analysis. Curr. Protoc. Immunol. Unit 11.3:1-11.
23. Shyu YJ, Hu CD. 2008. Fluorescence complementation: an emerging tool for biological research. Trends Biotechnol. 26:622-630. http://dx.doi.org/10.1016/j.tibtech.2008.07.006.
24. Wong KA, O'Bryan JP. 2011. Bimolecular fluorescence complementation. J. Vis. Exp. 2011:e2643. http://dx.doi.org/10.1016/S0091-679X(08)85019-4.
25. Das M, Scappini E, Martin NP, Wong KA, Dunn S, Chen YJ, Miller SL, Domin J, O'Bryan JP. 2007. Regulation of neuron survival through an intersectin-phosphoinositide 3=-kinase C2beta-AKT pathway. Mol. Cell. Biol. 27:7906-7917. http://dx.doi.org/10.1128/MCB.01369-07.
26. Burmeister BT, Taglieri DM, Wang L, Carnegie GK. 2012. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart. J. Biol. Chem. 287:40535-40546. http://dx.doi.org/10.1074/jbc. M112.385641.
27. Fong CW, Leong HF, Wong ES, Lim J, YusoffP, Guy GR. 2003. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J. Biol. Chem. 278:33456-33464. http://dx.doi.org/10.1074/jbc. M301317200.
28. Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y. 2003. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr. Biol. 13:297-307. http://dx.doi.org/10.1016/S0960-9822(03)00053-8.
29. Hall AB, Jura N, DaSilva J, Jang YJ, Gong D, Bar-Sagi D. 2003. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr. Biol. 13:308-314. http://dx.doi.org/10.1016/S0960-9822(03)00086-1.
30. Mason JM, Morrison DJ, Bassit B, Dimri M, Band H, Licht JD, Gross I. 2004. Tyrosine phosphorylation of Sprouty proteins regulates their abil-ity to inhibit growth factor signaling: a dual feedback loop. Mol. Biol. Cell 15:2176-2188. http://dx.doi.org/10.1091/mbc. E03-07-0503.
31. Wong ES, Lim J, Low BC, Chen Q, Guy GR. 2001. Evidence for direct interaction between Sprouty and Cbl. J. Biol. Chem. 276:5866-5875. http://dx.doi.org/10.1074/jbc. M006945200.
32. Quintanar-Audelo M, YusoffP, Sinniah S, Chandramouli S, Guy GR. 2011. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway. J. Biol. Chem. 286: 23102-23112. http://dx.doi.org/10.1074/jbc. M110.212662.
33. Agazie YM, Hayman MJ. 2003. Development of an efficient "substratetrapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J. Biol. Chem. 278:13952-13958. http://dx.doi.org/10.1074/jbc. M210670200.
34. Novokhatska O, Dergai M, Tsyba L, Skrypkina I, Filonenko V, Moreau J, Rynditch A. 2013. Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domaincontaining proteins. PLoS One 8:e70546. http://dx.doi.org/10.1371/journal.pone.0070546.
35. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450. http://dx.doi.org/10.1016/S0092-8674(00)80938-1.
36. Kim HJ, Taylor LJ, Bar-Sagi D. 2007. Spatial regulation of EGFR signaling by Sprouty2. Curr. Biol. 17:455-461. http://dx.doi.org/10.1016/j.cub.2007.01.059.
37. Hunter MP, Nelson M, Kurzer M, Wang X, Kryscio RJ, Head E, Pinna G, O'Bryan JP. 2011. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome. Neuroreport 22:767-772. http://dx.doi.org/10.1097/WNR.0b013e32834ae348.
38. Keating DJ, Chen C, Pritchard MA. 2006. Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res. Rev. 5:388-401. http://dx.doi.org/10.1016/j.arr.2005.11.001.
39. Nixon RA. 2005. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging 26:373-382. http://dx.doi.org/10.1016/j.neurobiolaging.2004.09.018.